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Abstract
We have used the obligate aerobic yeast Yarrowia lipolytica to reconstruct and analyse three missense mutations in the
nuclear coded subunits homologous to bovine TYKY and PSST of mitochondrial complex I (proton translocating
NADH:ubiquinone oxidoreductase) that have been shown to cause Leigh syndrome (MIM 25600), a severe progressive
neurodegenerative disorder. While homozygosity for a V122M substitution in NDUFS7 (PSST) has been found in two
siblings with neuropathologically proven Leigh syndrome (R. Triepels et al., Ann. Neurol. 45 (1999) 787), heterozygosity for
a P79L and a R102H substitution in NDUFS8 (TYKY) has been found in another patient (J. Loeffen et al., Am. J. Hum.
Genet. 63 (1998) 1598). Mitochondrial membranes from Y. lipolytica strains carrying any of the three point mutations
exhibited similar complex I defects, with Vmax being reduced by about 50%. This suggests that complex I mutations that
clinically present as Leigh syndrome may share common characteristics. In addition changes in the Km for n-decyl-
ubiquinone and I50 for hydrophobic complex I inhibitors were observed, which provides further evidence that not only the
hydrophobic, mitochondrially coded subunits, but also some of the nuclear coded subunits of complex I are involved in its
reaction with ubiquinone. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Complex I, the ¢rst enzyme of the respiratory
chain, is also the largest and least understood one.
In mammals, it has a Mr of almost 1000 and consists
of 43 di¡erent subunits [1], seven of which are en-
coded by the mitochondrial genome. Its size and
complexity has proven a major obstacle to the anal-
ysis of complex I. Since a semiquinone radical is a
natural intermediate in the electron transfer reaction
from NADH to ubiquinone, it is also an important
source of reactive oxygen species (ROS) [2]. Conse-
quently, a large number of genetic disorders are
caused by mutations in complex I. While the role
of mtDNA mutations [3,4] as a major contributor
to complex I de¢ciency (MIM 252010) has been
widely recognised, recent ¢ndings have shown that
mutations in nuclear encoded subunits of complex I
are also fairly common among the group of congen-
ital OXPHOS defects and can result in diverse path-
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ologies. In a group of 60 patients with isolated com-
plex I defects described by Robinson, the most com-
mon clinical presentation, however, was Leigh syn-
drome with or without cardiomyopathy [2]. Leigh
syndrome, or subacute necrotising encephalomyelop-
athy, is a severe, progressive neurodegenerative dis-
order with an estimated incidence of about 1:40 000
in live births. It is a genetically heterogenous entity
which may display autosomal recessive inheritance
caused by defects in the genes for biotinidase [5],
pyruvate dehydrogenase complex (PDHc), OXPHOS
complex II [6] or IV [7], X-linked inheritance caused
by defects in the E1K subunit of the PDHc [8], or
maternal inheritance associated with defects in sub-
unit 6 of ATP synthetase [9,10], tRNA(Lys) [11],
tRNA(Trp) [12], tRNA(Val) [13], tRNA(Leu) [14]
and MERFF mutations A8344G [15] and A3242G
[16].
Recently, researchers at the Nijmegen Center for
Mitochondrial Disorders (Nijmegen, The Nether-
lands) have identi¢ed point mutations in genes for
subunits of complex I as the causative genetic defects
in two cases of neuropathologically proven Leigh
syndrome that resulted in death in early infancy.
One patient was found to carry a homozygous
G364A transition in the NDUFS7 gene encoding
the homologue of the PSST subunit of bovine heart
complex I [17], resulting in a V122M substitution.
Another patient was compound heterozygous for
two transitions (C236T, resulting in P79L and
G305A, resulting in R102H) in the NDUFS8 gene
encoding the homologue of the TYKY subunit of
bovine heart complex I [18]. All three mutations
were completely recessive, since no clinical symptoms
could be detected in the heterozygous parents.
NADH:ubiquinone-1 oxidoreductase activity was
low in all tissues examined, suggesting that a reduc-
tion in the electron transfer and/or proton pumping
activities of complex I can cause Leigh syndrome.
The intriguing ¢nding that the three nuclear Leigh
syndrome point mutations a¡ecting complex I de-
scribed so far reside in central complex I subunits
of unclear catalytic function and involve residues
that are fully conserved among eucaryotes prompted
us to reconstruct them in the obligate aerobic yeast
Yarrowia lipolytica by site-directed mutagenesis of
the genes homologous to human NDUFS7 and
NDUFS8. We have recently established Y. lipolytica
as a new model system for the analysis of complex I
[19]. This organism combines the powerful tools of
yeast genetics [20] with the possession of a respira-
tory chain complex I that is stable enough to allow
straightforward puri¢cation (Djafarzadeh Andabili et
al., submitted). This approach allows the in vitro
characterisation of mutant forms of complex I. In
particular, we were interested in the case of the two
compound heterozygous mutations in NDUFS8,
where the relative contribution of the two di¡erent
mutant forms to total complex I activity was unclear.
2. Materials and methods
2.1. Substrates and inhibitors
n-Decyl-ubiquinone (DBQ), deamino-NADH
(dNADH), hexamine-ruthenium(III)-chloride (HAR)
and rotenone were purchased from Sigma. DQA was
a generous gift from Aventis CropScience, Frankfurt
am Main.
2.2. Strains
Y. lipolytica strains E129 (MatA, lys11-23, ura3-
302, leu2-270, xpr2-322) and E150 (MatB, his-1,
ura3-302, leu2-270, xpr2-322) were a kind gift from
Prof. C. Gaillardin, INRA, Paris, France. The dip-
loid strain GB1 was produced by mating E129 and
E150. Y. lipolytica genetic techniques were carried
out according to [20].
2.3. Deletion of NUKM and NUIM, the Y. lipolytica
homologues of PSST and TYKY
The isolation of the Y. lipolytica NUKM and
NUIM genes (Djafarzadeh Andabili et al., submit-
ted) and the deletion of the NUKM gene by homol-
ogous recombination with a LEU2 marked deletion
allele [19] have been described previously. The
NUIM gene was deleted by homologous recombina-
tion with a LEU2 marked deletion allele as follows:
a 2.6 kb SalI fragment from genomic clone A3 was
digested with BamHI and partially with PstI, remov-
ing the NUIM open reading frame (ORF) except for
the ¢rst 20 and last ten amino acids. Into this 0.6 kb
gap the Y. lipolytica LEU2 marker gene was inserted
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in opposite orientation to the original NUIM ORF
as a 1.9 kb PCR product, ampli¢ed using primers
containing the appropriate restriction sites. The re-
sulting 4.0 kb fragment was isolated and used for
transformation of diploid Y. lipolytica cells (geno-
type: his+/3, lys+/3, leu2/leu2, ura3/ura3). Leucine
prototrophs were checked for homologous recombi-
nation by Southern blotting and PCR using combi-
nations of outward primers derived from the LEU2
sequence and inward primers derived from genomic
sequences £anking the fragment used for transforma-
tion.
2.4. Site-directed mutagenesis of Y. lipolytica
A 2.8 kb HindIII partial fragment containing the
complete NUIM gene or a 2.3 kb EcoRI fragment
containing the complete NUKM gene were subcloned
into the Y. lipolytica replicative plasmid pINA443
which carries the Y. lipolytica URA3 marker gene.
Point mutations were created using the QuikChange
Site-Directed Mutagenesis Kit from Stratagene. Mu-
tated plasmids were con¢rmed by DNA sequencing
and used for transformation of the corresponding
heterozygous deletion strain. Haploids carrying the
chromosomal deletion and the plasmid-borne mutant
allele were isolated after sporulation by their proto-
trophy for leucine and uracil. LEU2, URA3 spores
were tested for absence of the genomic copy of
NUIM or NUKM by PCR or Southern blotting
and the mutation was recon¢rmed by sequencing of
the entire open reading frame on the plasmid.
2.5. Functional analysis
Unsealed mitochondrial membranes were isolated
as described previously [21]. dNADH:DBQ oxidore-
ductase activity which is speci¢c for complex I was
assayed at 30‡C essentially as described [21] with 50
Wg/ml unsealed mitochondrial membranes, 100 WM
dNADH and 60 WM DBQ in a bu¡er containing
50 mM Tris-HCl, pH 7.4 and 2 mM KCN. NADH:
HAR activity which only relies on a functional 51
kDa subunit and is speci¢c for complex I was used as
a measure for complex I content [19] and assayed
at 200 WM NADH and 2 mM HAR in 20 mM
Na/HEPES, pH 8.0 and 2 mM KCN at 30‡C.
Michaelis-Menten parameters were determined by
varying the concentration of DBQ (0^100 WM). I50
values for DQA and rotenone were determined by
adding the inhibitor from an ethanolic stock solution
to the proceeding reaction. Data were analysed using
the ENZFITTER programme (Elsevier).
3. Results
Cloning of the genes for the seven nuclear coded
subunits of complex I that are conserved between
bacteria and eucaryotic cells has shown that the com-
plex I subunit homologous to human NDUFS8 and
bovine TYKY is encoded by the Y. lipolytica NUIM
gene and the complex I subunit homologous to hu-
man NDUFS7 and bovine PSST is encoded by the
Y. lipolytica NUKM gene (Djafarzadeh Andabili et
al., submitted).
Alignments of the proteins homologous to bovine
PSST (encoded by the NUKM genes of Y. lipolytica
and Neurospora crassa and human NDUFS7) and of
the proteins homologous to bovine TYKY (encoded
by the NUIM genes of Y. lipolytica and N. crassa
and human NDUFS8) demonstrate that all proteins
are extremely well conserved among ascomycetous
fungi and mammals in the regions a¡ected by the
Leigh mutations (cf. Fig. 1). V119 in the NUKM
protein of Y. lipolytica corresponds to V122 in
NDUFS7. It is part of a short, highly conserved
stretch of hydrophobic amino acids that is predicted
form a L-sheet by the method of Chou and Fasman
[22]. It is separated by 32 and 30 amino acid residues,
respectively, from conserved cysteines that could
serve as ligands for iron-sulfur cluster N2. This
part of the protein is also well conserved in procar-
yotes like Paracoccus denitri¢cans and Escherichia
coli.
P98 and R121 in the NUKM protein of Y. lipo-
lytica correspond to P79 and R102 in NDUFS8.
These residues are immediately upstream from the
¢rst out of two CXXCXXCXXXCP motifs, that
may coordinate two tetranuclear iron-sulfur clusters
of the ferrodoxin-type (cf. Fig. 1).
P98 is not conserved in E. coli, but proline residues
are found immediately adjacent to this position in
P. denitri¢cans, Rhodobacter capsulatus and Thermus
aquaticus. It is striking that although overall se-
quence homology in this region is low between eu-
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caryotes and procaryotes, four prolines have been
conserved during evolution in identical positions.
This may indicate an important function for these
residues in determining the three-dimensional struc-
ture of the TYKY subunit. R121 lies at the begin-
ning of an evolutionary well conserved region which
encompasses the ¢rst CXXCXXCXXXCP motif. It
is the ¢rst out of two consecutive arginine residues
found in all TYKY homologues, again with the ex-
ception of E. coli, where it is replaced by threonine
and only the following arginine is conserved. Some
degree of sequence deviation between complex I sub-
units from E. coli and from other procaryotes is
commonly observed. This may partly be due to func-
tional speci¢cation, since complex I from E. coli can
use both ubiquinone and menaquinone as substrates
and, as has been observed recently, translocates so-
dium ions instead of or in addition to protons [23].
Both the Y. lipolytica NUIM and NUKM genes
were deleted in diploid cells by homologous recombi-
nation with a LEU2 marked deletion allele. The de-
letion strategy for the NUIM gene is shown in Fig. 2.
Leigh syndrome point mutations were created by
site-directed mutagenesis, cloned into the single-
copy replicative plasmid pINA443 and haploids car-
rying the deletion allele and the plasmid-borne mu-
tant copy were isolated by sporulation and random
spore analysis. The growth characteristics of all three
mutants were comparable to haploid wild type
strains, indicating that the complex I mutations did
not markedly a¡ect cell viability. Blue-native polyac-
rylamide gel electrophoresis [24] of isolated mito-
chondrial membranes demonstrated that the mutant
versions of complex I were fully assembled and that
the expression level of complex I in the mutants was
comparable to wild type (data not shown).
For the determination of Michaelis-Menten pa-
rameters Vmax and Km for DBQ, complex I activity
of mitochondrial membranes was assayed as electron
transfer from dNADH to DBQ (cf. Fig. 3). Catalytic
rates were normalised according to their NADH:
HAR activity, which depends only on the presence
of a functional 51 kDa subunit and can be used as a
measure for total complex I content in di¡erent
Fig. 1. Positions of Leigh mutations in the PSST and TYKY homologues of Y. lipolytica. The protein sequences from various organ-
isms were aligned using the CLUSTAL programme of the HUSAR 4.0 package (DKFZ Heidelberg, Germany). Identical amino acids
are marked by asterisks. Residues forming the ¢rst half of the ferredoxin-type binding motif in TYKY and conserved cysteines in
PSST are shaded in gray. The positions of the Leigh mutations are marked with arrows and the position of the residue in the Y. lipo-
lytica protein is indicated.
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batches of mitochondrial membranes. In all three
mutants, Vmax was found to be signi¢cantly reduced
by about 50%. The Km for DBQ was una¡ected in
the NUIM R121H mutant, while it was reduced from
around 20 WM to 12 WM in the NUKM V119M
(PSST) and the NUIM P98L (TYKY) mutants.
These two mutants also exhibited a tendency to high-
er I50 values for the class B inhibitor rotenone. As
indicated by a somewhat lowered I50, the NUIM
R121H and the NUKM V119M mutants exhibited
a slight hypersensitivity to the type A inhibitor DQA.
Type C inhibitors were not tested, as the activity of
Y. lipolytica complex I has shown to be completely
insensitive towards these compounds [19]. All data
are summarised in Table 1.
4. Discussion
Point mutations within mitochondrially coded
complex I subunits, such as ND4/11778, ND1/3460
or ND6/14484, have been identi¢ed in patients af-
fected with Lebers hereditary optic neuropathy
(LHON) [25]. In contrast to the mutation in ND4,
there is a considerable decrease in complex I activity
associated with the mutations in ND1 and ND6 [26].
The analysis of mutation ND1/3460, resulting in an
A52T substitution [27,28], and of mutations of
strictly conserved residues in its vicinity using the
bacterium P. denitri¢cans [29] has demonstrated
that this region plays an important role in ubiqui-
Fig. 2. Construction of the NUIM: :LEU2 deletion allele (A) and deletion of the genomic copy by homologous recombination (B).
The NUIM open reading frame is shaded in dark gray. PCR primer pairs (ylleu2/us, nTYKY/1) and (ylleu2/ds, nTYKY/2) were used
to screen LEU2 colonies for marker insertion by homologous recombination. Restriction sites: B, BamHI; P, PstI; S, SalI.
Fig. 3. Kinetic characterization of Leigh mutants in NUIM and
NUKM. Km and Vmax values were determined by direct ¢t of
the data to the standard Michaelis-Menten equation. These pa-
rameters (cf. Table 1) were used to construct the shown double-
reciprocal plots of the parental strain and the three Leigh mu-
tants. F, parental strain; R, mutant NUKM V119M; 8, mu-
tant NUIM P98L; b, mutant NUIM R121H.
BBABIO 44915 4-8-00
P.M. Ahlers et al. / Biochimica et Biophysica Acta 1459 (2000) 258^265262
none reduction by complex I. The A52T substitution
displayed an almost twofold increase in the Km for
DBQ, but Vmax was only reduced by about 10%.
Other mtDNA point mutations, such as ND4/
11696 and ND6/14459, cause LHON with additional
dystonia, accompanied by lesions in the caudate and
putamen visible on MRI [30,31]. While the unravel-
ling of these mtDNA mutations has ¢rmly estab-
lished the functional role of mitochondrially encoded
subunits in the interaction of complex I with the
substrate ubiquinone, recent ¢ndings have underlined
the importance of nuclear coded subunits in ubiqui-
none binding and reduction as well as in the proton
translocating function of the enzyme. The 49 kDa
homologue is the target of a piericidin A resistant
mutation in R. capsulatus [32]. Bovine PSST can be
labelled with a photoreactive derivative of pyridaben
[33] and point mutations in NUKM, the homologue
of this subunit in Y. lipolytica, lead to resistance to
DQA and hypersensitivity to rotenone [19]. Iron-sul-
fur cluster N2, which stands out by the striking pH
dependence of its midpoint potential [34], is generally
assumed to act as the direct reductant for ubiquinone
and has been proposed to be directly involved in
proton translocation [35,36]. Based on mutagenesis
studies in E. coli [37] and R. capsulatus [38], both
PSST and TYKY, respectively, have been proposed
to carry iron-sulfur cluster N2. The recent ¢nding
that conserved acidic residues in the PSST homo-
logue of Y. lipolytica interact with cluster N2 and
may contribute to a network of hydrogen bonds
that channels protons to or away from cluster N2
[19] supports the view that this subunit is involved
in proton translocation by complex I. It is remark-
able that all these functionally important subunits,
namely the 49 kDa, PSST, TYKY and ND1, togeth-
er with ND5 are conserved between complex I and
membrane-bound Ni-Fe hydrogenases from arche-
bacteria [39]. These subunits may be regarded as
the catalytic core of the enzyme and appear as prime
candidates for deleterious mutations a¡ecting its cat-
alytic function.
In the present work we have analysed the e¡ect of
three mutations identi¢ed in patients a¡ected with
Leigh syndrome that are located in two subunits of
this catalytic core of complex I, namely PSST and
TYKY. The point mutations involved residues that
are fully conserved among eucaryotes and were re-
constructed in the obligate aerobic yeast Y. lipolytica,
a new model system which allows the application of
the powerful methods of yeast genetics to the analy-
sis of mitochondrial complex I. This approach may
not only help to understand the aetiology of Leigh
syndrome, which could involve reduced electron
transport and proton pumping e⁄ciency or the gen-
eration of harmful radical oxygen species, but should
also provide useful hints on catalytically important
regions within complex I.
We have therefore examined the in vitro kinetics of
the Leigh mutant versions of complex I from Y. lipo-
lytica, in order to detect alterations in the interaction
between complex I and the substrate ubiquinone or
its inhibitory analogues. We found that all three mu-
tations a¡ected electron transport (Table 1, Fig. 3):
Vmax of complex I in mitochondrial membranes was
reduced by about 50% in all three mutant strains.
Among the two point mutations found in
NDUFS8/NUIM, the R121H missense mutation re-
sulted in a lower Vmax than the P98L mutation. Re-
markably, for two mutants, NUKM V119M and
NUIM P98L, the Km for ubiquinone was decreased
by about a factor of two to 12 WM, resulting in an
unchanged speci¢city constant as compared to the





% Km (WM) DQA (nM) Rotenone (WM)
Parental 0.44 þ 0.02 100 22 þ 2 20 0.5
NUKM V119M 0.22 þ 0.01 50 12 þ 1 10 0.7
NUIM P98L 0.25 þ 0.01 57 12 þ 1 20 0.7
NUIM R121H 0.20 þ 0.01 45 19 þ 2 10 0.5
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a¡ect the inhibitory potency of DQA and/or rote-
none, but these e¡ects were not very pronounced
(cf. Table 1). Thus, the reconstruction of the human
Leigh mutations in the yeast Y. lipolytica indeed re-
sulted in catalytically impaired complex I. In contrast
to the LHON mutation ND1/3460 that was recon-
structed in P. denitri¢cans [29], a substantial reduc-
tion of Vmax, but an unchanged or even lowered Km
for DBQ, was observed in all three mutants studied
here. When using a microorganism as a model, it is
inherently impossible to ¢nd out how a given func-
tional defect at the level of complex I translates into
characteristic organ and tissue speci¢c patterns of
malfunction that is then diagnosed as a certain hu-
man disorder. However, the observation that the mu-
tations in NUKM and NUIM had so similar e¡ects
on Vmax of complex I and cause Leigh syndrome, but
that mutation ND1/3460 increases the Km for DBQ
but leaves Vmax almost unchanged [29] and causes
LHON may provide a ¢rst clue towards a molecular
understanding of the aetiology of human disorders
caused by complex I defects.
With regard to the structure/function relationships
in complex I our results provide yet another indica-
tion that some of the nuclear coded subunits are
directly involved in quinone chemistry and may
even be part of the quinone reactive site of complex
I as suggested previously [32]. It seems sensible to
assume that the quinone head group of ubiquinone
must be bound to the hydrophilic part of complex I,
in order to come close to its direct reductant, cluster
N2. The quinone tail may still interact mainly with
the membrane part of the enzyme, e.g. with the ND1
subunit, mutations which are known to reduce the
a⁄nity of complex I for ubiquinone, and the ND5
subunit, which is also among the core subunits con-
served between membrane bound Ni-Fe hydroge-
nases from archaea and complex I.
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